Gryphon Therapeutics
About:
Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.
Website: http://www.gryphonsci.com
Top Investors: SR One, Forward Ventures, Sprout Group
Description:
Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications.
Total Funding Amount:
$26M
Headquarters Location:
San Francisco, California, United States
Founded Date:
1993-01-01
Founders:
Number of Employees:
Last Funding Date:
2002-01-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai